Comparative risk of uveitis with Janus kinase inhibitors versus tumor necrosis factor inhibitors in ankylosing spondylitis and psoriatic diseases: a target trial emulation study

ObjectivesTo compare the risk of incident uveitis among patients with axial spondyloarthritis initiating treatment with Janus kinase inhibitors (JAKi) versus tumor necrosis factor inhibitors (TNFi).MethodsWe conducted an emulated target trial using real-world electronic health records from the TriNe...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Wei-Hsuan Bai, Pei-Lun Liao, Yi-Chiao Bai, James Cheng-Chung Wei
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2025-10-01
Edice:	Frontiers in Immunology
Témata:	janus kinase inhibitors tumor necrosis factor inhibitors uveitis autoimmune disease TriNetX cohort study
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1673970/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!